Shinjuku-ku, Japan

Noriko Kinoshita


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noriko Kinoshita: Innovator in Respiratory Infection Prediction

Introduction

Noriko Kinoshita is a prominent inventor based in Shinjuku-ku, Japan. She has made significant contributions to the field of medical technology, particularly in the prediction of respiratory infections. Her innovative approach has the potential to enhance patient care and improve health outcomes.

Latest Patents

Kinoshita holds a patent for a method and device that assists in predicting the exacerbation of respiratory infections. The patent, titled "Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection," involves measuring specific biomarkers in specimens collected from subjects suffering from or suspected of having respiratory infections. The biomarkers include IFNλ3, CCL17, CXCL11, IP-10, IL-6, and CXCL9. The measured values of these biomarkers serve as indices to predict the exacerbation of respiratory infections. She has 1 patent to her name.

Career Highlights

Throughout her career, Kinoshita has worked with esteemed organizations such as the National Center for Global Health and Medicine and Sysmex Corporation. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Masashi Mizokami and Masaya Sugiyama. Their collaborative efforts have further advanced the research and development of innovative solutions in healthcare.

Conclusion

Noriko Kinoshita's contributions to the field of respiratory infection prediction exemplify her dedication to improving medical technology. Her innovative methods and collaborations with esteemed professionals highlight her impact on healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…